Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

View All Documentation

481904

Sigma-Aldrich

5-Fluoro-2-nitrobenzoic acid

98%

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
FC6H3(NO2)CO2H
CAS Number:
320-98-9
Molecular Weight:
185.11
MDL number:
MFCD00055635
UNSPSC Code:
12352100
PubChem Substance ID:
24871795
NACRES:
NA.22

assay

98%

mp

131-134 °C (lit.)

SMILES string

OC(=O)c1cc(F)ccc1[N+]([O-])=O

InChI

1S/C7H4FNO4/c8-4-1-2-6(9(12)13)5(3-4)7(10)11/h1-3H,(H,10,11)

InChI key

GHYZIXDKAPMFCS-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

5-Fluoro-2-nitrobenzoic acid, an ortho-nitro benzoic acid derivative, can be prepared by the oxidation of 5-fluoro-2-nitrotoluene. It is an intermediate formed during the synthesis of N1-(2,4-dichlorophenyl)-2-amino-5-fluorobenzamide. It participates in the synthesis of novel quinazolinones that are potential inhibitors of p38α mitogen-activated protein kinase (MAPK).

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Solution and solid-phase approaches to quinconazole and fluquinconazole-inhibitors of fungal ergosterol biosynthesis.
Bilokin YV and Kovalenko SM.
Heterocyclic Communications, 6(5), 409-414 (2000)
Dearg S Brown et al.
Bioorganic & medicinal chemistry letters, 22(12), 3879-3883 (2012-05-23)
A novel, potent and selective quinazolinone series of inhibitors of p38α MAP kinase has been identified. Modifications designed to address the issues of poor aqueous solubility and high plasma protein binding as well as embedded aniline functionalities resulted in the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service